June 3, 2014 / 6:38 AM / 3 years ago

BRIEF-Bayer says to evaluate Riociguat in new indication

FRANKFURT, June 3 (Reuters) - Bayer AG : * Says Bayer to evaluate riociguat in new indication * Says phase iib study to investigate riociguat in pulmonary hypertension

associated with idiopathic interstitial pneumonia

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below